CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- SC 13D/A Stake Beneficial Ownership Report
- 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 5,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- 4 Option exercise Director acquired 2,500 shares (option exercise)
- 4 Option exercise Director acquired 2,500 shares (option exercise)
- UPLOAD Other SEC-generated Letter
- SC 13G Stake Amended Statement of Ownership
- S-3 Offering Registration Statement
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Results of operations
Page 18 of 46 · 909 filings